The Hera Clinic Brings the Future of Aesthetic Wellness to Singapore
Now Introducing Profhilo Structura: The Latest in Injectable Skin Lifting
Featuring Ultherapy Prime, Morpheus8, and Profhilo Structura for Natural, Lasting Results
SINGAPORE, June 26, 2025 /PRNewswire/ -- Located in the heart of Singapore, The Hera Clinic is redefining modern beauty with advanced, evidence-based aesthetic treatments for both women and men. With a focus on personalised care and innovative technology, the clinic continues to set new benchmarks in aesthetic medicine in Singapore.
Profhilo Structura: Next-Generation Injectable for Lifting & Volume through fat rejuvenation
Launching this week, Profhilo Structura represents a breakthrough in non-surgical facial rejuvenation at The Hera Clinic. Unlike traditional fillers, Profhilo Structura is formulated with Nahyco® Hybrid Technology. This unique hyaluronic acid injectable delivers natural-looking volume and skin lifting with no downtime. The treatment rejuvenates fat compartments, enhances skin architecture, and provides a refreshed, youthful appearance without the long-term complications associated with conventional fillers.[1][2]
For a limited period, The Hera Clinic is offering exclusive pricing for Profhilo Structura. In July, clients can enjoy three sessions (2cc per syringe per session) plus one complimentary Profhilo (2cc per syringe) at $3,000. Ongoing packages and August exclusive rates are also available. Ongoing packages and August exclusive rates are also available.
To learn more about this innovative treatment and see if it is right for you, please visit the Profhilo Structura page.
"With Profhilo Structura, our clients can enjoy visible lifting and volumising results without recovery time. It's designed for today's busy lifestyles," says the medical team at The Hera Clinic.
Ultherapy Prime: Pioneers in Non-Invasive Skin Lifting
The Hera Clinic is one of the first clinics in Singapore to offer Ultherapy Prime, introduced in December 2024. While this technology only became more widely available in March 2025, the clinic's early adoption demonstrates its commitment to non-invasive skin tightening.
Ultherapy Prime uses focused ultrasound energy to stimulate collagen production, resulting in firmer, lifted skin on the face, neck, and jawline. Treatments are non-surgical and require no downtime.[3][4]
Learn more on our Ultherapy Prime treatment page.
Morpheus8: Reshape and Renew Your Skin
Since opening, The Hera Clinic has offered Morpheus8, a revolutionary treatment that combines microneedling with radiofrequency (RF) energy. Morpheus8 targets deeper layers of the skin, triggering collagen production for comprehensive skin tightening, improved texture, and fat remodelling. The procedure is FDA-cleared and suitable for all skin types, with minimal discomfort and little to no downtime.[5][6]
Whether you are looking to refine fine lines, reduce acne scars, address sagging, or improve stretch marks, Morpheus8 provides visible, natural results on the face, neck, and body.
Learn more about Morpheus8 in Singapore and its benefits.
"Build your skin: Stronger, Smoother, Tighter with Morpheus8 at The Hera Clinic."
Exclusive June 2025 Pricing
Valid until 30 June 2025. Terms and Conditions apply.
The Hera Clinic is making advanced aesthetic treatments more accessible with these June pricing:
Ultherapy Prime: $1999 for 600 lines (full face & jawline)
Biostimulator CaHa or PLLA: $2488 for 3 syringes/bottles
Salmon DNA Hb Plus: $488 for 2 syringes (1ml/syringe)
For more information, please visit The Hera Clinic's official website.
The Hera Clinic Experience: Comfort Meets Clinical Excellence
At The Hera Clinic, clients receive more than just results. Our team delivers medical precision, advanced technology, and personalised care in a welcoming environment. Every treatment is tailored to your needs and designed to support your long-term wellness and confidence.
Beauty and Wellness for Every Lifestyle
Whether you're addressing early signs of ageing, skin laxity after weight loss, or seeking all-over rejuvenation, The Hera Clinic's comprehensive menu, including Ultherapy Prime, Morpheus8, and Profhilo Structura, offers effective, natural-looking solutions for a wide range of skin concerns.
Contact The Hera Clinic
For general enquiries and bookings:WhatsApp: 98207641
For media enquiries only:Call: 65142374Vivien Yeap, Clinic Manager: 93222996
Book your consultation and discover the future of aesthetic wellness at The Hera Clinic today.
The Hera Clinic Official Website
References:
[1]The Beauty Doctors. "Profhilo Before and After Results." https://thebeautydoctors.co.uk/blog/profhilo-before-and-after-results/
[2]RealSelf. "Profhilo Reviews & Information." https://www.realself.com/nonsurgical/profhilo
[3]VIDA Skin Clinic. "What is Ultherapy Prime and How Does It Work?" https://vidaskinclinic.com/what-is-ultherapy-prime-and-how-does-it-work/
[4]IDS Aesthetics. "Ultherapy Prime – Ultrasound Lifting Treatment." https://www.idsaesthetics.com/beauty-tips/ultherapy-prime-ultrasound-lifting-treatment
[5]RealSelf. "Morpheus8 Reviews & Information." https://www.realself.com/nonsurgical/morpheus8
[6]Select Women's Healthcare. "Morpheus8 Skin Tightening." https://selectwomenshealthcare.com/morpheus8-skin-tightening/
View original content:https://www.prnewswire.com/apac/news-releases/the-hera-clinic-brings-the-future-of-aesthetic-wellness-to-singapore-302491206.html
SOURCE The Hera Clinic
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Autoimmune Disease Diagnostics Market to Reach $11.45 Billion by 2032, Growing at a CAGR of 7.5% from 2025, Says Meticulous Research®
Market Growth Driven by Rising Prevalence of Autoimmune Disorders, Emphasis on Early Diagnosis, Advanced Biosensor Technologies, and Growing Healthcare Awareness REDDING, Calif., June 30, 2025 /PRNewswire/ -- According to a comprehensive market research report titled "Autoimmune Disease Diagnostics Market Size, Share, Forecast, & Trends Analysis By Product (Reagents, Kits, Assays, Instruments), Test Type (ANA, CRP, ESR, Rheumatoid Factor, Routine Test), Disease Type (Systemic, Localized) - Global Forecast to 2032," the Autoimmune Disease Diagnostics market is projected to reach $11.45 billion by 2032, up from an estimated $6.91 billion in 2025, growing at a robust CAGR of 7.5% during the forecast period. The growth of the autoimmune disease diagnostics market is driven by the increasing prevalence of autoimmune disorders, the growing emphasis on early diagnosis, and the rising awareness regarding autoimmune diseases. The market's expansion is fueled by advanced biosensor technologies, sophisticated diagnostic solutions, and the critical need for rapid and accurate detection of autoimmune conditions across diverse patient populations. The industry is experiencing revolutionary transformation through the integration of cutting-edge biosensor technologies, AI-powered diagnostic platforms, and development of highly specific biomarker detection systems. Leading companies are embracing digital diagnostic solutions while expanding into emerging markets and developing innovative point-of-care testing capabilities for healthcare providers worldwide. For more comprehensive insights, download the FREE report sample: Revolutionary Market Transformation Through Advanced Diagnostic Excellence The autoimmune disease diagnostics market represents a paradigm shift in healthcare delivery and patient outcomes optimization. As healthcare providers increasingly prioritize early detection and accurate diagnosis of complex autoimmune conditions, advanced diagnostic solutions offer a revolutionary approach that addresses the growing demand for cost-effective, highly sensitive, and technologically sophisticated autoimmune disease detection capabilities. Market leaders are investing heavily in biosensor technologies and biomarker research, establishing diagnostic capabilities that can deliver rapid, accurate, and patient-specific autoimmune disease detection. This technological advancement is making sophisticated autoimmune diagnostics increasingly accessible while delivering superior accuracy and clinical outcomes benefits. Dynamic Growth Across Key Market Segments Based on product type, the Reagents, Assays, & Kits segment dominates the market in 2025, capturing approximately 84% of the total market share due to high diagnosis rates of autoimmune diseases in developed countries, recurring purchase patterns, and growing availability of convenient diagnostic solutions. This segment is also experiencing the fastest growth with 7.4% CAGR, driven by increasing product launches, cost-effectiveness, and ease of use in clinical settings. Based on test type, the Antinuclear Antibodies (ANA) segment leads the market, reflecting its critical role in early detection of autoimmune diseases, high sensitivity for primary screening, and widespread clinical adoption. This segment is anticipated to record the highest growth rate of 8.3% during the forecast period, driven by the advantages of ANA testing including early disease detection capabilities and comprehensive autoimmune screening benefits. Based on disease type, the Systemic Autoimmune Diseases segment accounts for the larger market share, attributed to high prevalence of conditions like rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus affecting multiple organ systems. This segment is expected to maintain strong growth throughout the forecast period. Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) - Strategic Market Opportunities and Innovation Drivers The market presents extraordinary growth opportunities through biosensor technology integration, emerging market expansion, and development of specialized point-of-care diagnostic solutions. Companies are discovering new revenue streams through advanced biomarker detection capabilities and comprehensive diagnostic service portfolios while establishing integrated autoimmune disease management ecosystems. Key market drivers include: Rising Disease Prevalence: Increasing incidence of autoimmune disorders globally, with approximately 24 million people in the U.S. suffering from autoimmune diseases, driving demand for accurate diagnostic solutions Early Diagnosis Emphasis: Growing recognition of the importance of early detection in reducing disability, morbidity, and mortality associated with autoimmune diseases Advanced Biosensor Technologies: Integration of sophisticated biosensor platforms utilizing antibodies, antigens, and peptides for highly specific biomarker detection and improved diagnostic accuracy Healthcare Awareness Growth: Expanding public and healthcare provider awareness about autoimmune diseases, supported by initiatives from organizations like the Autoimmune Association promoting education and early intervention Regional Market Leadership and Emerging Growth North America commands the largest market share in 2025 with approximately 39% of the global market, driven by high prevalence of autoimmune diseases, advanced diagnostic infrastructure, presence of leading diagnostic companies, and significant healthcare expenditure supporting widespread adoption of sophisticated diagnostic technologies. Asia-Pacific emerges as the fastest-growing region with a projected CAGR of 9.7% during 2025-2032, propelled by increasing prevalence of celiac disease and rheumatoid arthritis, adoption of unhealthy lifestyles due to urbanization, government initiatives addressing autoimmune diseases, and rising investments in autoimmune disease research and diagnostic capabilities. Europe represents a significant market, supported by advanced healthcare systems, strong regulatory frameworks, growing demand for precision diagnostics, and presence of leading diagnostic technology providers with emphasis on quality and clinical accuracy. Request a customized research analysis tailored to your specific requirements: Dynamic Competitive Landscape Driving Innovation The global autoimmune disease diagnostics market features an innovative competitive ecosystem comprising specialized diagnostic companies, biotechnology firms, and integrated healthcare technology providers. This diverse landscape fosters rapid technological advancement through sophisticated biosensor integration and specialized biomarker research development. Industry leaders are implementing integrated solutions that combine advanced diagnostic technologies with comprehensive testing portfolios and quality assurance capabilities. Companies are pursuing strategic partnerships and acquisitions while addressing scalability and accessibility challenges across different healthcare settings and patient populations. Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More) - Market Leaders Shaping Industry Future Key players driving the global autoimmune disease diagnostics market include Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Abbott Laboratories (U.S.), Becton, Dickinson, and Company (U.S.), PerkinElmer, Inc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Siemens Healthineers AG (Germany), Grifols, S.A. (Spain), and Creative Diagnostics (U.S.). These companies are focusing on strategies such as advanced biosensor technology development, comprehensive diagnostic portfolio expansion, point-of-care testing solutions, strategic partnerships and acquisitions, and geographic expansion into emerging markets to strengthen their market position and enhance diagnostic accessibility. Latest Industry Developments Recent market developments include: Biosensor Technology Advancement: Development of innovative biosensor platforms for rapid, sensitive, and cost-effective autoimmune disease detection using electrochemical, piezoelectric, and optical sensing technologies Biomarker Research Integration: Enhanced focus on autoantibody (AAb) detection and other specific biomarkers including chemokines, cytokines, and proteins for improved diagnostic accuracy and disease monitoring Point-of-Care Solutions: Strategic initiatives to develop portable and user-friendly diagnostic devices enabling rapid testing in hospitals, clinics, and healthcare facilities Market Challenges and Opportunities While the market shows strong growth potential, it faces challenges including difficulties in accurate diagnosis of autoimmune diseases due to complex symptom patterns, unfavorable reimbursement scenarios in certain regions, high rates of delayed diagnosis or misdiagnosis, and regulatory compliance requirements across different jurisdictions. However, significant opportunities exist in expanding biosensor technology adoption, growing healthcare expenditure in developing countries, increasing demand for personalized diagnostic solutions, emerging applications in digital health and connected diagnostic devices, and rising need for specialized diagnostic expertise in complex autoimmune conditions. The diagnostic laboratories segment continues to dominate due to skilled workforce availability, high-throughput processing capabilities, and advanced instrumentation. However, the hospitals & clinics segment is projected to experience the highest growth, driven by increasing adoption of point-of-care testing and expanding diagnostic capabilities at primary care facilities. Related Reports: In Vitro Diagnostics (IVD) Market Size, Share, Forecast, & Trends Analysis Molecular Diagnostics Market Size, Share, Forecast, & Trends Analysis Livestock Diagnostics Market Size, Share, Forecast, & Trends Analysis IVD Reagents Market Size, Share, Forecast, & Trends Analysis About Meticulous Research® We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions—including syndicated reports, custom research, and direct analyst engagement. To find out more, visit or follow us on LinkedIn Contact: Mr. Khushal BombeMeticulous Market Research Pvt. Ltd.1267 Willis St, Ste 200 Redding,California, 96001, +1-646-781-8004Europe: +44-203-868-8738APAC: +91 744-7780008Email- sales@ Visit Our Website: with us on LinkedIn- Content Source: Logo: View original content: SOURCE Meticulous Market Research Pvt. Ltd. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
3 hours ago
- Business Wire
Quantum Health Sets New Standard for Transparency and Value in Healthcare Navigation Amid Growing Employer Concerns About Escalating Costs
DUBLIN, Ohio--(BUSINESS WIRE)-- Quantum Health, the creator of healthcare navigation, today announced the launch of its new comprehensive intervention and value reporting capability, Action to Impact, which proves – at the member level – how its healthcare navigation model reduces costs, improves outcomes and enhances employee experience. Powered by a dynamic AI engine and 25 years of proprietary data, Action to Impact provides transparent, actionable evidence, connecting specific navigation actions to quantifiable results. "We don't just show engagement metrics — we connect employers to real savings, better care and improved member experiences.' - Chris Reed, Director of Value Creation, Quantum Health Share This launch comes at a time when self-insured employers are demanding more from their healthcare and benefits investments. According to the newly released State of Healthcare Survey 2025: The Transformative Power of Trust in Healthcare by Arizent and Employee Benefit News (EBN), sponsored by Quantum Health, 79% of employers identified company cost as the top concern they are focused on addressing in their latest annual benefits cycle. While these value-driving interactions have long been part of Quantum's model, Action to Impact offers a new way to package and share insights with clients and consultants, while giving internal teams real-time feedback for continuous improvement. The solution connects every touchpoint, from navigation and steerage to clinical support, continuously optimizing member and provider experiences to improve clinical, financial and satisfaction outcomes. By transforming traditional ROI into specific, actionable insights, Quantum Health proves the value of its interventions for each client. "Proving our ability to drive better outcomes at a lower cost has never been more essential. Today's clients expect more than anecdotes — they demand data-driven answers to their most pressing questions,' said Chris Reed, Director of Value Creation at Quantum Health. 'Employers want specifics: What actions were taken? What actually worked? With Action to Impact, Quantum Health delivers those answers through advanced analytics that quantify how navigation interventions reduce costs and improve outcomes." At the heart of Quantum Health's approach is its proprietary Real-Time Intercept® (RTI) platform, which enables member engagement an average of 110 days before the first claim — often before costs or complexity escalate. These early 'value moments' offer critical opportunities to influence care decisions and outcomes, allowing Quantum Health clients to achieve better health and financial results through meaningful, proactive engagement. These results are independently validated by MorningStar Actuarial Consulting, whose study of 2018-2022 claims data finds that Quantum Health's navigation and care coordination solution produces substantial and steadily accumulating ROI. Why This Matters — Self-insured employers are under pressure to do more with less – and prove it. As HR teams seek to optimize every dollar spent, Quantum Health's Action to Impact analytics deliver the insight needed to rise to that challenge. "Trust is a key part of the value equation for employees,' said Kerry Gross, Director of Research Intelligence at Arizent. 'Those who trust that the entities supporting their care have their best interests in mind are more likely to get preventive primary care and more likely to be satisfied with their overall wellness offerings." Employers are turning to data to guide their healthcare decisions. The EBN State of Healthcare survey indicates that utilization data (88%) and insurance claims data (84%) are reported as the most trusted sources. Meanwhile, 53% of employers say they are confident their navigation partner can demonstrate how member engagement translates into cost savings. Still, just under half are only somewhat or slightly confident that engagement and cost savings data is being clearly tied together. "We don't just show engagement metrics — we connect them to real savings, better care and improved member experiences,' added Reed. 'Our enhanced reporting pinpoints the most complex journeys, identifies where the greatest value is created, and outlines next steps to maximize results. As our dataset matures, insights become even more predictive, helping clients stay ahead of emerging challenges." To explore the full results of the 2025 State of Healthcare study, visit About Employee Benefit News Employee Benefit News (EBN) is the leading media resource for decision-makers in employee benefits, HR, and workplace culture. EBN provides critical insights to help business leaders navigate shifting industry dynamics, reduce care costs, improve retirement plans, and build diverse, high-performing workforces. Learn more at About Arizent Research Arizent delivers actionable insights through full-service research solutions powered by first-party data, expert perspectives, and engaged professional communities. Its portfolio includes trusted brands across financial services and professional sectors, such as American Banker, Financial Planning, Accounting Today, and Employee Benefit News. For more, visit About Quantum Health Celebrating 25 years of innovation, Quantum Health is a leading consumer healthcare navigation and care coordination company. Its Real-Time Intercept® platform identifies early intervention opportunities to improve engagement, outcomes, and cost efficiency. Based in Dublin, Ohio, Quantum Health has earned national recognition for growth and workplace culture, including honors from FORTUNE, Inc. 5000, and the Women Presidents' Organization. To learn more, visit and connect on LinkedIn.
Associated Press
3 hours ago
- Associated Press
Quantum Health Sets New Standard for Transparency and Value in Healthcare Navigation Amid Growing Employer Concerns About Escalating Costs
DUBLIN, Ohio--(BUSINESS WIRE)--Jun 30, 2025-- Quantum Health, the creator of healthcare navigation, today announced the launch of its new comprehensive intervention and value reporting capability, Action to Impact, which proves – at the member level – how its healthcare navigation model reduces costs, improves outcomes and enhances employee experience. Powered by a dynamic AI engine and 25 years of proprietary data, Action to Impact provides transparent, actionable evidence, connecting specific navigation actions to quantifiable results. This press release features multimedia. View the full release here: This launch comes at a time when self-insured employers are demanding more from their healthcare and benefits investments. According to the newly released State of Healthcare Survey 2025: The Transformative Power of Trust in Healthcare by Arizent and Employee Benefit News (EBN), sponsored by Quantum Health, 79% of employers identified company cost as the top concern they are focused on addressing in their latest annual benefits cycle. While these value-driving interactions have long been part of Quantum's model, Action to Impact offers a new way to package and share insights with clients and consultants, while giving internal teams real-time feedback for continuous improvement. The solution connects every touchpoint, from navigation and steerage to clinical support, continuously optimizing member and provider experiences to improve clinical, financial and satisfaction outcomes. By transforming traditional ROI into specific, actionable insights, Quantum Health proves the value of its interventions for each client. 'Proving our ability to drive better outcomes at a lower cost has never been more essential. Today's clients expect more than anecdotes — they demand data-driven answers to their most pressing questions,' said Chris Reed, Director of Value Creation at Quantum Health. 'Employers want specifics: What actions were taken? What actually worked? With Action to Impact, Quantum Health delivers those answers through advanced analytics that quantify how navigation interventions reduce costs and improve outcomes.' At the heart of Quantum Health's approach is its proprietary Real-Time Intercept® (RTI) platform, which enables member engagement an average of 110 days before the first claim — often before costs or complexity escalate. These early 'value moments' offer critical opportunities to influence care decisions and outcomes, allowing Quantum Health clients to achieve better health and financial results through meaningful, proactive engagement. These results are independently validated by MorningStar Actuarial Consulting, whose study of 2018-2022 claims data finds that Quantum Health's navigation and care coordination solution produces substantial and steadily accumulating ROI. Why This Matters — Self-insured employers are under pressure to do more with less – and prove it. As HR teams seek to optimize every dollar spent, Quantum Health's Action to Impact analytics deliver the insight needed to rise to that challenge. 'Trust is a key part of the value equation for employees,' said Kerry Gross, Director of Research Intelligence at Arizent. 'Those who trust that the entities supporting their care have their best interests in mind are more likely to get preventive primary care and more likely to be satisfied with their overall wellness offerings.' Employers are turning to data to guide their healthcare decisions. The EBN State of Healthcare survey indicates that utilization data (88%) and insurance claims data (84%) are reported as the most trusted sources. Meanwhile, 53% of employers say they are confident their navigation partner can demonstrate how member engagement translates into cost savings. Still, just under half are only somewhat or slightly confident that engagement and cost savings data is being clearly tied together. 'We don't just show engagement metrics — we connect them to real savings, better care and improved member experiences,' added Reed. 'Our enhanced reporting pinpoints the most complex journeys, identifies where the greatest value is created, and outlines next steps to maximize results. As our dataset matures, insights become even more predictive, helping clients stay ahead of emerging challenges.' To explore the full results of the 2025 State of Healthcare study, visit About Employee Benefit News Employee Benefit News (EBN) is the leading media resource for decision-makers in employee benefits, HR, and workplace culture. EBN provides critical insights to help business leaders navigate shifting industry dynamics, reduce care costs, improve retirement plans, and build diverse, high-performing workforces. Learn more at About Arizent Research Arizent delivers actionable insights through full-service research solutions powered by first-party data, expert perspectives, and engaged professional communities. Its portfolio includes trusted brands across financial services and professional sectors, such as American Banker, Financial Planning, Accounting Today, and Employee Benefit News. For more, visit About Quantum Health Celebrating 25 years of innovation, Quantum Health is a leading consumer healthcare navigation and care coordination company. Its Real-Time Intercept® platform identifies early intervention opportunities to improve engagement, outcomes, and cost efficiency. Based in Dublin, Ohio, Quantum Health has earned national recognition for growth and workplace culture, including honors from FORTUNE, Inc. 5000, and the Women Presidents' Organization. To learn more, visit and connect on LinkedIn. View source version on CONTACT: Media Contact:Alison Travis Corporate Communications, Quantum Health [email protected] 220-465-9386 KEYWORD: UNITED STATES NORTH AMERICA OHIO INDUSTRY KEYWORD: OTHER PROFESSIONAL SERVICES INSURANCE DATA ANALYTICS HUMAN RESOURCES HEALTH PROFESSIONAL SERVICES HEALTH INSURANCE OTHER HEALTH SOURCE: Quantum Health Copyright Business Wire 2025. PUB: 06/30/2025 08:15 AM/DISC: 06/30/2025 08:15 AM
